Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19

Journal of Thrombosis and Haemostasis : JTH
Rushad PatellJeffrey I Zwicker

Abstract

Coronavirus disease-2019 (COVID-19) is a recognized prothrombotic state. Patients hospitalized with active cancer are predisposed to thrombosis but whether active cancer further amplifies thrombotic risk with COVID-19 is not known. To evaluate cumulative incidences of thrombotic and hemorrhagic events in hospitalized COVID-19 patients with and without active cancer at 28 days. A retrospective cohort analysis of consecutive adults hospitalized with COVID-19 was performed. Active cancer required cancer-directed therapy within previous 6 months. The cumulative incidences of thrombosis or hemorrhage were estimated considering death as a competing risk. Patients without cancer (n = 353) and active cancer (n = 45) were comparable in terms of age, sex, antibiotics administered, length of hospitalization, and critical care. The most common malignancies were lymphoid (17.8%), gastrointestinal (15.6%), lung (13.3%), and genitourinary (13.3%). At day 28, the cumulative incidence of thrombotic events was 18.2% (95% confidence interval [CI], 10.2%-27.9%) in the non-cancer cohort and 14.2% (95% CI, 4.7%-28.7%) in the cancer cohort. The cumulative incidence of major and fatal bleeding at day 28 was 20.8% (95% CI, 12.1%-31.0%) in the non-cance...Continue Reading

References

Aug 30, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Raza AlikhanAlexander G G Turpie
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alok A KhoranaGary H Lyman
Jul 10, 2007·Vascular Medicine·Alexander T CohenUNKNOWN PREVENT Medical Thromboprophylaxis Study Group
Sep 16, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna Falanga, Marina Marchetti
Nov 26, 2010·The New England Journal of Medicine·Christopher P LandriganPaul J Sharek
May 5, 2012·Journal of Thrombosis and Haemostasis : JTH·F CampigottoJ I Zwicker
Jul 5, 2013·Blood·Tiziano BarbuiAnna Falanga
Feb 28, 2017·American Journal of Hematology·Rushad PatellAlok A Khorana
May 29, 2018·The American Journal of Medicine·Benjamin BrennerUNKNOWN RIETE Investigators
Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng
Feb 19, 2020·The Lancet Oncology·Wenhua LiangJianxing He
Apr 9, 2020·Nature Reviews. Clinical Oncology·Peter Sidaway
Apr 21, 2020·Journal of the American College of Cardiology·Behnood BikdeliUNKNOWN Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working
Apr 24, 2020·Lancet·Zsuzsanna VargaHolger Moch
Apr 28, 2020·Blood·Jean M Connors, Jerrold H Levy
Apr 29, 2020·The New England Journal of Medicine·Thomas J OxleyJohanna T Fifi
Apr 30, 2020·Cell Research·Wei Cao, Taisheng Li
May 1, 2020·Thrombosis Research·Corrado LodigianiUNKNOWN Humanitas COVID-19 Task Force
May 6, 2020·Journal of Medical Virology·Fan YangXiaobei Chen
May 15, 2020·The Lancet. Haematology·Marcel LeviJerrold H Levy
May 30, 2020·JAMA Network Open·Julien NahumStéphane Thierry
Jun 1, 2020·Lancet·Nicole M KudererUNKNOWN COVID-19 and Cancer Consortium
Jun 17, 2020·Research and Practice in Thrombosis and Haemostasis·Kevin P CohoonAlex C Spyropoulos

❮ Previous
Next ❯

Citations

Oct 13, 2020·Research and Practice in Thrombosis and Haemostasis·Stephan NoppCihan Ay
Dec 29, 2020·Cancer Treatment and Research Communications·Kush GuptaEshan Patel
Feb 25, 2021·Thorax·Boun Kim TanJean-Christophe Lega
Mar 11, 2021·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Nicolas GallasteguiTimothy A Morris
Dec 24, 2020·Cancer Research·Lenard M Lichtenberger, K Vinod Vijayan
Oct 14, 2020·Cancer Cell·Ziad BakounyCorrie A Painter
Apr 10, 2021·Clinical Journal of Gastroenterology·Quentin BinetLeila Shaza
Apr 24, 2021·Journal of Thrombosis and Thrombolysis·Diana Paredes-RuizCarmen Díaz-Pedroche
Apr 9, 2021·Thrombosis and Haemostasis·Vicky MaiSteeve Provencher
Jun 9, 2021·Chest·Jacobo RogadoUNKNOWN Infanta Leonor Thrombosis Research Group
Jun 29, 2021·Acute Medicine & Surgery·Kazuma YamakawaUNKNOWN Special Committee of the Japanese Clinical Practice Guidelines for the Management of Sepsis, Septic Shock 2020 (J‐SSCG 2020)
Aug 5, 2021·Indian Journal of Surgical Oncology·Narendra HulikalKodaganuru S Gopinath
Sep 4, 2020·Journal of Thrombosis and Thrombolysis·Richard C Becker
Aug 31, 2021·European Heart Journal Supplements : Journal of the European Society of Cardiology·Irma BiscegliaFurio Colivicchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.